Good news for patients with metastatic cancer of unknown primary tumor (R) may bring therapeutic benefits

Wuxi, November 16, 2021/PRNewswire/ - Tissue of Origin® (Tissue of Origin®) launched by Wuxi Zhenhe Biotechnology Co.

There is a type of tumor in clinic, even through detailed medical history and complete auxiliary examination, the primary site cannot be determined.

The Tissue of Origin® test analyzes the RNA expression profiles of 4975 genes in tumor samples and compares them with the RNA expression patterns established in the database, and gives the most likely origin tissue analysis based on the score

Tissue of Origin® testing advantages

Certification authority--

The only testing product of its kind approved by FDA 510 (k)

Comprehensive cancer types--

Can distinguish more than 95% of solid tumors, including 17 tumor types and 69 tumor subtypes

Effective detection--

The positive agreement rate (similar sensitivity) is 89%; the negative exclusion rate (similar specificity) is 99%

The Tissue of Origin® detection product launched by Wuxi Zhenhe Biotechnology Co.

Source: Zhenhe Technology